These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4288409)

  • 41. [A case of Cushing's disease with paradoxical response to dexamethasone].
    Kubo M; Nakagawa K; Akikawa K; Matsubara M; Ishizuka T; Nakagawa S
    Nihon Naika Gakkai Zasshi; 1986 Jan; 75(1):75-82. PubMed ID: 3009668
    [No Abstract]   [Full Text] [Related]  

  • 42. [Considerations of the values of plasma corticotropic activity and their variations under the influence of various treatments in 8 cases of Cushing's disease].
    Decourt J; de Gennes JL; Bercovici JP
    Ann Endocrinol (Paris); 1968; 29(1):55-68. PubMed ID: 4298000
    [No Abstract]   [Full Text] [Related]  

  • 43. [Intercurrent relationships between nyctohemeral rhythm of elimination of gonadotropins and adrenal cortex steroids].
    Abate G; Bernardi P; Allegro G
    Folia Endocrinol; 1967 Apr; 20(2):234-46. PubMed ID: 4294757
    [No Abstract]   [Full Text] [Related]  

  • 44. Adrenocortical function in obesity and Cushing's syndrome.
    Hankin ME; Theile HM; Steinbeck AW
    Clin Sci Mol Med; 1974 Aug; 47(2):119-29. PubMed ID: 4411885
    [No Abstract]   [Full Text] [Related]  

  • 45. Anomalous responses to stimulation and suppression tests in Cushing's syndrome due to a calcified adrenal adenoma.
    Epstein S; Goldin AR; McLaren EH
    Postgrad Med J; 1973 Dec; 49(578):923-6. PubMed ID: 4377169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of adrenal autonomy in Cushing's syndrome: a comparison between in vivo and in vitro responsiveness of the adrenal gland.
    Lamberts SW; Zuiderwijk J; Uitterlinden P; Blijd JJ; Bruining HA; de Jong FH
    J Clin Endocrinol Metab; 1990 Jan; 70(1):192-9. PubMed ID: 2152930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pituitary-adrenocortical studies in a patient with Cushing's syndrome induced by thymoma.
    Miura K; Sasaki C; Katsushima I; Ohtomo T; Sato S; Demura H; Torikai T; Sasano N
    J Clin Endocrinol Metab; 1967 May; 27(5):631-7. PubMed ID: 4290580
    [No Abstract]   [Full Text] [Related]  

  • 48. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recurrent Cushing's disease following "total" adrenalectomy.
    Siegal AM; Kreisberg RA; Hershman JM; Owen WC
    Arch Intern Med; 1972 Apr; 129(4):642-7. PubMed ID: 4336309
    [No Abstract]   [Full Text] [Related]  

  • 50. Cushing's syndrome due to unilateral adrenal nodular hyperplasia with incomplete inhibition of the contralateral gland.
    Catania A; Reschini E; Orsatti A; Motta P; Airaghi L; Cantalamessa L
    Horm Res; 1986; 23(1):9-15. PubMed ID: 3000913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing's syndrome.
    Tyrrell JB; Findling JW; Aron DC; Fitzgerald PA; Forsham PH
    Ann Intern Med; 1986 Feb; 104(2):180-6. PubMed ID: 3004275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of responsiveness to L-dopa in Cushing's disease.
    Krieger DT
    J Clin Endocrinol Metab; 1973 Feb; 36(2):277-84. PubMed ID: 4345691
    [No Abstract]   [Full Text] [Related]  

  • 53. Growth hormone and cortisol responsiveness in Cushing's syndrome. Relation to a possible central nervous system etiology.
    Krieger DT; Glick SM
    Am J Med; 1972 Jan; 52(1):25-40. PubMed ID: 5058357
    [No Abstract]   [Full Text] [Related]  

  • 54. Corticosteroid secretion: responses to alpha1-24 corticotropin, metyrapone and dexamethasone.
    Frawley TF
    Trans Am Clin Climatol Assoc; 1972; 83():45-56. PubMed ID: 4339147
    [No Abstract]   [Full Text] [Related]  

  • 55. Short stature as the only clinical sign of Cushing's syndrome.
    Lee PA; Weldon VV; Migeon CJ
    J Pediatr; 1975 Jan; 86(1):89-91. PubMed ID: 162955
    [No Abstract]   [Full Text] [Related]  

  • 56. [Studies on the secretion and metabolism of cortisol in obesity and Cushing's disease].
    Cassano C; Scavo D; Jacobelli A
    Ann Endocrinol (Paris); 1968; 29(1):5-15. PubMed ID: 4298001
    [No Abstract]   [Full Text] [Related]  

  • 57. Severe osteopenia in young adults associated with Cushing's syndrome due to micronodular adrenal disease.
    Ruder HJ; Loriaux DL; Lipsett MB
    J Clin Endocrinol Metab; 1974 Dec; 39(6):1138-47. PubMed ID: 4372247
    [No Abstract]   [Full Text] [Related]  

  • 58. [I. Evaluation of the hypothalamo-hypophyseal-adrenal function. Effects of the administration of ACTH, dexamethasone, metopirone and L-dopa on the steroids of urine in normal patients].
    Charro Salgado AL; Bagazgoitia J; López Macia A; Oriol Bosch A; Fernández Cruz A
    Rev Clin Esp; 1976 May; 141(3):221-6. PubMed ID: 180569
    [No Abstract]   [Full Text] [Related]  

  • 59. Cushing's disease in a boy: serial steroid and growth hormone studies.
    Chen R; Kenny FM; Drash AL
    Johns Hopkins Med J; 1969 Sep; 125(3):134-45. PubMed ID: 4902217
    [No Abstract]   [Full Text] [Related]  

  • 60. Observations and comments on failure of dexamethasone suppression.
    Linn JE; Bowdoin B; Farmer TA; Meador CK
    N Engl J Med; 1967 Aug; 277(8):403-5. PubMed ID: 4378314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.